Compositions, methods and kits are provided for preparing an atoxic C. difficile protein that elicits an immune response in the subject specific for TcdA and TcdB. Atoxic Clostridium difficile toxin proteins were expressed in an endotoxin-free Bacillus system to develop a vaccine to reduce or treat incidence and severity of C. difficile infection (CDI).